Amneal to Participate at Upcoming Investor Conferences in May
May 13 2022 - 8:00AM
Business Wire
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) today
announced that its investor relations or management team will
attend the following investor conferences:
RBC Healthcare Conference May 17, 2022 Investor Relations Hosted
Meetings New York, New York
UBS Healthcare Conference May 25, 2022 Investor Relations Hosted
Meetings New York, New York
Barclays CEO Call Series May 27, 2022 Fireside Chat – 10:00am
Eastern Time
About Amneal Amneal Pharmaceuticals, Inc. (NYSE: AMRX),
headquartered in Bridgewater, NJ, is a fully-integrated essential
medicines company. We make healthy possible through the
development, manufacturing, and distribution of generic and
specialty pharmaceuticals, primarily within the United States. The
Company has a diverse portfolio of over 250 products in its
Generics segment and is expanding across a broad range of complex
products and therapeutic areas, including injectables and
biosimilars. In its Specialty segment, Amneal has a growing
portfolio of branded pharmaceutical products focused primarily on
central nervous system and endocrine disorders, with a pipeline
focused on unmet needs. Through its AvKARE segment, the Company is
a distributor of pharmaceuticals and other products for the U.S.
federal government, retail, and institutional markets. For more
information, please visit www.amneal.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220513005062/en/
Tony DiMeo Head of Investor Relations
Anthony.DiMeo@amneal.com
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amneal Pharmaceuticals (NYSE:AMRX)
Historical Stock Chart
From Apr 2023 to Apr 2024